1. Home
  2. SVRA vs ADTN Comparison

SVRA vs ADTN Comparison

Compare SVRA & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • ADTN
  • Stock Information
  • Founded
  • SVRA N/A
  • ADTN 1985
  • Country
  • SVRA United States
  • ADTN United States
  • Employees
  • SVRA N/A
  • ADTN N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • ADTN Telecommunications Equipment
  • Sector
  • SVRA Health Care
  • ADTN Telecommunications
  • Exchange
  • SVRA Nasdaq
  • ADTN Nasdaq
  • Market Cap
  • SVRA 590.4M
  • ADTN 656.7M
  • IPO Year
  • SVRA N/A
  • ADTN 1994
  • Fundamental
  • Price
  • SVRA $3.23
  • ADTN $8.19
  • Analyst Decision
  • SVRA Buy
  • ADTN Strong Buy
  • Analyst Count
  • SVRA 7
  • ADTN 3
  • Target Price
  • SVRA $9.86
  • ADTN $10.33
  • AVG Volume (30 Days)
  • SVRA 1.4M
  • ADTN 624.3K
  • Earning Date
  • SVRA 11-12-2024
  • ADTN 11-06-2024
  • Dividend Yield
  • SVRA N/A
  • ADTN N/A
  • EPS Growth
  • SVRA N/A
  • ADTN N/A
  • EPS
  • SVRA N/A
  • ADTN N/A
  • Revenue
  • SVRA N/A
  • ADTN $905,347,000.00
  • Revenue This Year
  • SVRA N/A
  • ADTN N/A
  • Revenue Next Year
  • SVRA N/A
  • ADTN $10.32
  • P/E Ratio
  • SVRA N/A
  • ADTN N/A
  • Revenue Growth
  • SVRA N/A
  • ADTN N/A
  • 52 Week Low
  • SVRA $2.82
  • ADTN $4.34
  • 52 Week High
  • SVRA $5.70
  • ADTN $9.21
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 45.22
  • ADTN 50.25
  • Support Level
  • SVRA $2.99
  • ADTN $8.03
  • Resistance Level
  • SVRA $3.36
  • ADTN $8.87
  • Average True Range (ATR)
  • SVRA 0.23
  • ADTN 0.39
  • MACD
  • SVRA -0.02
  • ADTN -0.12
  • Stochastic Oscillator
  • SVRA 28.74
  • ADTN 13.56

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.

Share on Social Networks: